Brief: NeuroVive Reports Progress In Clinical Project KL1333

Abliva AB

11/12/2017 10:00

Dec 11 (Reuters) - NEUROVIVE PHARMACEUTICAL AB  NVP.ST : 
    * NEUROVIVE REPORTS PROMISING PROGRESS IN ITS CLINICAL 
PROJECT FOR 
GENETIC MITOCHONDRIAL DISEASES, KL1333 
    * - PHARMACOKINETIC DATA WAS IN LINE WITH EXPECTATIONS AND 
NO 
ADVERSE SAFETY SIGNALS WERE DETECTED 
    * MULTIPLE-DOSE, PHASE IB STUDY IS PLANNED TO BE INITIATED 
IN 
EUROPE AND/OR U.S. IN 2018 
 
Source text for Eikon:  ID:nWkr4KtxqZ  
Further company coverage:  NVP.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))